Dopamine/serotonin receptor ligands.: Part 17:: A cross-target SAR approach:: Affinities of azecine-styled ligands for 5-HT2A versus D1 and D2 receptors

被引：8
|
作者：
Enzensperger, Christoph [1 ]
Goernemann, Tilo [2 ]
Pertz, Heinz H. [2 ]
Lehmann, Jochen [1 ]
机构：
[1] Univ Jena, Inst Pharm, Lehrstuhl Pharmazeut Med Chem, D-07743 Jena, Germany
[2] Free Univ Berlin, Inst Pharm, D-14195 Berlin, Germany
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2008年 / 18卷 / 13期
关键词：
dopamine; serotonin; receptor ligand; azecine; cross-target SAR; protein-ligand interaction;
D O I：
10.1016/j.bmcl.2008.04.081
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Dibenzo- and benzindolo-azecines represent a novel class of high-affinity dopamine receptor antagonists. To further characterize these drugs as potential neuroleptics, we selected a set of azecine derivatives and ring expanded homologues and we measured their antagonist activity at the 5-HT(2A) receptor in the porcine coronary artery. SARs found for the 5-HT(2A) receptor resemble those for the D(1) but not the D(2) receptor. The protein-ligand interactions were discussed with respect to the different binding pockets. (c) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码：3809 / 3813
页数：5
相关论文
共 50 条
  • [21] EFFECT OF N-ALKYLATION ON THE AFFINITIES OF ANALOGS OF SPIPERONE FOR DOPAMINE D2 AND SEROTONIN 5-HT2 RECEPTORS
    MACH, RH
    JACKSON, JR
    LUEDTKE, RR
    IVINS, KJ
    MOLINOFF, PB
    EHRENKAUFER, RL
    JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (03) : 423 - 430
  • [22] Dopamine D2 and serotonin 5-HT1A receptors of the brain in processing of pain
    Pertovaara, A.
    Martikainen, I. K.
    Hagelberg, N.
    Hirvonen, J.
    Scheinin, H.
    Hietala, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S113 - S113
  • [23] Chemical synthesis, microbial transformation and biological evaluation of tetrahydroprotoberberines as dopamine D1/D2 receptor ligands
    Ge, Haixia
    Zhang, Yan
    Yang, Zhuo
    Qiang, Kun
    Chen, Chao
    Sun, Laiyu
    Chen, Ming
    Zhang, Jian
    BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (10) : 2100 - 2111
  • [24] Chronic administration of clozapine increases the level of serotonin 5-HT1A receptor heterodimerisation with 5-HT2A or D2 receptors in the mouse cortex
    Szlachta, M.
    Faron-Gorecka, A.
    Kusmider, M.
    Pabian, P.
    Kolasa, M.
    Solich, J.
    Zurawek, D.
    Dziedzicka-Wasylewska, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2018, 28 : S7 - S8
  • [25] A positron emission tomography occupancy study of brexpiprazole at dopamine D2 and D3 and serotonin 5-HT1A and 5-HT2A receptors, and serotonin reuptake transporters in subjects with schizophrenia
    Ragy R. Girgis
    Andy Forbes
    Anissa Abi-Dargham
    Mark Slifstein
    Neuropsychopharmacology, 2020, 45 : 786 - 792
  • [26] A positron emission tomography occupancy study of brexpiprazole at dopamine D2 and D3 and serotonin 5-HT1A and 5-HT2A receptors, and serotonin reuptake transporters in subjects with schizophrenia
    Girgis, Ragy R.
    Forbes, Andy
    Abi-Dargham, Anissa
    Slifstein, Mark
    NEUROPSYCHOPHARMACOLOGY, 2020, 45 (05) : 786 - 792
  • [27] Estrogen Treatment Blocks 8-Hydroxy-2-dipropylaminotetralin- and Apomorphine-Induced Disruptions of Prepulse Inhibition: Involvement of Dopamine D1 or D2 or Serotonin 5-HT1A, 5-HT2A, or 5-HT7 Receptors
    Gogos, Andrea
    Kwek, Perrin
    Chavez, Carolina
    van den Buuse, Maarten
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 333 (01): : 218 - 227
  • [28] Novel, highly potent and selective serotonin 5-HT2A/dopamine D2 receptor antagonists as potential antipsychotics.
    Lee, TK
    Robichaud, AJ
    Boyle, KE
    Lu, YM
    Chen, WT
    McClung, C
    Deng, W
    Miller, KJ
    McElroy, JF
    Largent, BL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U17 - U17
  • [29] Computational approaches for the design of novel dopamine D2 and serotonin 5-HT2A receptor dual antagonist towards schizophrenia
    Akash Rathore
    Vivek Asati
    Mitali Mishra
    Ratnesh Das
    Varsha Kashaw
    Sushil Kumar Kashaw
    In Silico Pharmacology, 10 (1)
  • [30] Effects of chronic clozapine and haloperidol treatments on dopamine D1, D2 and serotonin 5-HT2C receptors in rat brain.
    Huang, N
    Radja, F
    Hebert, C
    vanGelder, NM
    Reader, TA
    JOURNAL OF NEUROCHEMISTRY, 1996, 66 : S59 - S59
12345